Afficher la notice abrégée

dc.contributor.authorBaillache, Daniel J.
dc.contributor.authorValero Griñán, María Teresa 
dc.contributor.authorLorente Macías, Álvaro
dc.contributor.authorBennett, David Jonathan
dc.contributor.authorElliott, Richard J. R.
dc.contributor.authorCarragher, Neil O.
dc.contributor.authorUnciti-Broceta, Asier
dc.date.accessioned2023-11-09T11:59:33Z
dc.date.available2023-11-09T11:59:33Z
dc.date.issued2023
dc.identifier.citationBaillache, D. J., Valero, T., Lorente-Macías, Á., Bennett, D. J., Elliott, R., Carragher, N., & Unciti-Broceta, A. (2023). Discovery of pyrazolopyrimidines that selectively inhibit CSF-1R kinase by iterative design, synthesis and screening against Glioblastoma cells. RSC Medicinal Chemistry.[DOI: 10.1039/d3md00454f]es_ES
dc.identifier.urihttps://hdl.handle.net/10481/85552
dc.description.sponsorshipWe are grateful to Medical Research Scotland (PHD-1046-2016) for funding and a joint Cancer Research UK (A28596) and The Brain Tumour Charity award (GN-000676) to N. O. C. T. V. thanks EU Horizon 2020 research and innovation programme under the Marie Skls PHD-1046-2016es_ES
dc.description.sponsorshipMedical Research Scotland A28596es_ES
dc.description.sponsorshipCancer Research UK GN-000676es_ES
dc.description.sponsorshipBrain Tumour Charity award 749299es_ES
dc.description.sponsorshipEuropean Union (EU)es_ES
dc.description.sponsorshipMSDes_ES
dc.language.isoenges_ES
dc.rightsAtribución-NoComercial 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/*
dc.titleDiscovery of pyrazolopyrimidines that selectively inhibit CSF-1R kinase by iterative design, synthesis and screening against glioblastoma cellses_ES
dc.typejournal articlees_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/H2020/1046-2016es_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.1039/d3md00454f
dc.type.hasVersionVoRes_ES


Fichier(s) constituant ce document

[PDF]

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

Atribución-NoComercial 4.0 Internacional
Excepté là où spécifié autrement, la license de ce document est décrite en tant que Atribución-NoComercial 4.0 Internacional